Anzeige
Mehr »
Mittwoch, 17.09.2025 - Börsentäglich über 12.000 News
Die Ethereum-Vorreiter: Wie Republic Technologies die Infrastruktur der Zukunft aufbaut
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
110 Leser
Artikel bewerten:
(0)

Pharmapod Partners With FIP to Improve Patient Safety

AMMAN, Jordan, April 25, 2019 /PRNewswire/ -- The International Pharmaceutical Federation (FIP) and Pharmapod have today signed a partnership, to offer an infrastructure for effective incident management and continuous quality improvement for pharmacists internationally.

Pharmapod Logo (PRNewsfoto/Pharmapod)

Medication errors are a significant global problem, impacting millions of lives daily. In response to the World Health Organization's Patient Safety Challenge to reduce these errors by 50% over the next 5 years, pharmacists as medication experts are taking a lead role in developing and adopting effective solutions to improve processes across the healthcare system and prevent patient harm.

Pharmapod are driving worldwide change in patient safety with its Global Learning Health System. This is an award-winning, professionally-led solution which has rolled out across pharmacies, hospitals and long-term care facilities internationally - for example, it is the mandated system for the largest medication safety program of its kind in Canada, involving over 4,500 pharmacies.

The system helps drive improvements in quality and efficiencies in process, which are demonstrable and measurable for healthcare professionals. In addition to incorporating artificial intelligence tools such as machine learning into its technology, Pharmapod are now also connecting experts in medication safety internationally through establishing national response teams in each country to analyse the medication error data and develop improvement strategies.

FIP is recognised as the leader of pharmacy at a global level. Through its 144 membership organisations, its academic institutional members and individual members, it represents over four million pharmacists and pharmaceutical scientists around the world. FIP continues to expand its presence within pharmacy, the pharmaceutical sciences and pharmacy education, and to influence the pharmacy profession through partnerships with some of the world's leading health, policymaking, education and science institutions.

"The shared aims and goals of our two organisations provide the perfect environment to formalise existing collaborations and joint working, which is an important step forward for Pharmapod and FIP, now and in the future. Having two international organisations working in mutually beneficial and positive ways provides an excellent framework for similar collaborations at local levels, which we will both support and encourage through our agreed work programmes in FIP Education, specifically our Workforce Development Hub. We look forward to working closely with our global partners, commonwealth partners and member organisations," said FIP CEO Catherine Duggan.

Pharmapod CEO Leonora O'Brien added: "Being a pharmacist myself, it is a particular honour to collaborate with FIP and contribute to our profession. Given their unique remit, the FIP team has a 360 view on international pharmacy practice which is very exciting for us. We share a global vision and our professional goals and values are aligned. Pharmacists in every country provide an extraordinary service to their public. By harnessing technology, we can strengthen communications across the profession, helping pharmacists share their expertise and accelerate improvements in practice. To improve our health systems, we have to progress from the existing 'walled gardens' - we need to be able to share data and learn from each other. This is what Pharmapod's partnership with FIP aims to achieve."

For more information on Pharmapod, visit https://www.pharmapodhq.com.

Logo: https://mma.prnewswire.com/media/811918/Pharmapod_Logo.jpg

© 2019 PR Newswire
Solarbranche vor dem Mega-Comeback?
Lange galten Solaraktien als Liebling der Börse, dann kam der herbe Absturz: Zinsschock, Überkapazitäten aus China und ein Preisverfall, der selbst Marktführer wie SMA Solar, Enphase Energy oder SolarEdge massiv unter Druck setzte. Viele Anleger haben der Branche längst den Rücken gekehrt.

Doch genau das könnte jetzt die Chance sein!
Die Kombination aus KI-Explosion und Energiewende bringt die Branche zurück ins Rampenlicht:
  • Rechenzentren verschlingen Megawatt – Solarstrom bietet den günstigsten Preis je Kilowattstunde
  • Moderne Module liefern Wirkungsgrade wie Atomkraftwerke
  • hina bremst Preisdumping & pusht massiv den Ausbau
Gleichzeitig locken viele Solar-Aktien mit historischen Tiefstständen und massiven Short-Quoten, ein perfekter Nährboden für Kursrebound und Squeeze-Rally.

In unserem exklusiven Gratis-Report zeigen wir dir, welche 4 Solar-Aktien besonders vom Comeback profitieren dürften und warum jetzt der perfekte Zeitpunkt für einen Einstieg sein könnte.

Laden Sie jetzt den Spezialreport kostenlos herunter, bevor die Erholung am Markt beginnt!

Dieses Angebot gilt nur für kurze Zeit – also nicht zögern, jetzt sichern!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.